ReCor Medical
Shannon Nash has a diverse work experience in the medical and veterinary fields. Shannon is currently employed at ReCor Medical as the Manager of Preclinical Research since October 2021. Prior to this role, they worked as a Clinical Scientist at ReCor Medical from September 2019 to September 2021. In 2021, Shannon also founded Integrative Home Veterinary Services, PC, where they work as a Veterinarian and Practice Owner. Before that, they worked as a Veterinarian at Covance from December 2018 to September 2019, and as an Associate Veterinarian at Banfield Pet Hospital from June 2017 to December 2018. Shannon also has research experience as a T35 Veterinary Research Fellow at Stanford University School of Medicine from May 2014 to August 2015. Additionally, they worked as a Senior Graduate Intern at Regeneron Pharmaceuticals from May 2003 to June 2013 and as a Veterinary Assistant at South Putnam Animal Hospital from August 2008 to January 2010.
Shannon Nash completed their education with a Bachelor of Science (BS) degree in Biology from Mercy College, where they attended from 2006 to 2010. Following this, they pursued their Doctor of Veterinary Medicine (DVM) degree from Western University of Health Sciences, graduating in 2017.
Additionally, Shannon Nash has obtained several certifications to enhance their professional skills. Shannon became a Certified Veterinary Acupuncturist through Chi University in March 2023. In May 2017, they earned a Business Certificate from the Veterinary Business Management Association. Shannon also obtained their Veterinarian license from the State of California and became a Category II Accredited Veterinarian through the USDA Animal and Plant Health Inspection Service (APHIS), both in June 2017. Furthermore, in May 2018, they obtained the Fear Free Certification from Fear Free LLC.
This person is not in the org chart
ReCor Medical
ReCor Medical has developed a unique therapeutic non-focused ultrasound system for performing renal denervation in patients with resistant hypertension. The PARADISE® technology (Percutaneous Renal Denervation System) includes a 6 French catheter with a cylindrical transducer that emits ultrasound energy circumferentially, allowing for a moreefficient renal denervation procedure.